Literature DB >> 8025988

Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method.

F P van Rugge1, E E van der Wall, S J Spanjersberg, A de Roos, N A Matheijssen, A H Zwinderman, P R van Dijkman, J H Reiber, A V Bruschke.   

Abstract

BACKGROUND: Quantitative measurement of wall motion is essential to assess objectively the functional significance of coronary artery disease. We developed a quantitative wall thickening analysis on stress magnetic resonance images. This study was designed to assess the clinical value of magnetic resonance imaging (MRI) during dobutamine stress for detection and localization of myocardial ischemia in patients with suspected coronary artery disease. METHODS AND
RESULTS: Thirty-nine consecutive patients with clinically suspected coronary artery disease referred for coronary arteriography and 10 normal volunteers underwent gradient-echo MRI at rest and during peak dobutamine stress (infusion rate, 20 micrograms.kg-1.min-1). MRI was performed in the short-axis plane at four adjacent levels. Display in a cine loop provided a qualitative impression of regional wall motion (cine MRI). A modification of the centerline method was applied for quantitative wall motion analysis by means of calculation of percent systolic wall thickening. Short-axis cine MRI images were analyzed at 100 equally spaced chords constructed perpendicular to a centerline drawn midway between the end-diastolic and end-systolic contours. Dobutamine MRI was considered positive for coronary artery disease if the percent systolic wall thickening of more than four adjacent chords was < 2 SD below the mean values obtained from the normal volunteers. The overall sensitivity of dobutamine MRI for the detection of significant coronary artery disease (diameter stenosis > or = 50%) was 91% (30 of 33), specificity was 80% (5 of 6), and accuracy was 90% (35 of 39). The sensitivity for identifying one-vessel disease was 88% (15 of 17), for two-vessel disease 91% (10 of 11), and for three-vessel disease 100% (5 of 5). The sensitivity for detection of individual coronary artery lesions was 75% for the left anterior descending coronary artery, 87% for the right coronary artery, and 63% for the left circumflex coronary artery.
CONCLUSIONS: Dobutamine MRI clearly identifies wall motion abnormalities by quantitative analysis using a modification of the centerline method. Dobutamine MRI is an accurate method for detection and localization of myocardial ischemia and may emerge as a new noninvasive approach for evaluation of patients with known or suspected coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025988     DOI: 10.1161/01.cir.90.1.127

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  51 in total

Review 1.  Ischemic heart disease: value of MR techniques.

Authors:  E E van der Wall; F P van Rugge; H W Vliegen; J H Reiber; A de Roos; A V Bruschke
Journal:  Int J Card Imaging       Date:  1997-06

Review 2.  MR of acquired heart disease: ischemic heart disease.

Authors:  A E Stillman
Journal:  Int J Cardiovasc Imaging       Date:  2001-12       Impact factor: 2.357

3.  Improved functional cardiac MR imaging using the intravascular contrast agent CLARISCAN.

Authors:  I Paetsch; H Thiele; B Schnackenburg; A Bornstedt; A Müller-York; J Schwab; E Fleck; E Nagel
Journal:  Int J Cardiovasc Imaging       Date:  2003-08       Impact factor: 2.357

Review 4.  Magnetic resonance imaging assessment of cardiac function.

Authors:  W Gregory Hundley; Craig A Hamilton; Pairoj Rerkpattanapipat
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

5.  New automated Markov-Gibbs random field based framework for myocardial wall viability quantification on agent enhanced cardiac magnetic resonance images.

Authors:  Ahmed Elnakib; Garth M Beache; Georgy Gimel'farb; Ayman El-Baz
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-09       Impact factor: 2.357

6.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 7.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

Review 8.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

9.  Tetralogy of Fallot: in good shape?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-16       Impact factor: 2.357

10.  Rabbit models: ideal for imaging purposes?

Authors:  A van der Laarse; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-16       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.